Status:
ACTIVE_NOT_RECRUITING
The Impact of an Innovative eHealth Transition Intervention on Self-Management Skills Among Young Adults With Congenital Heart Disease
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
McGill University
Oregon Health and Science University
Conditions:
Congenital Heart Disease
Congenital Heart Disease in Adolescence
Eligibility:
All Genders
16-17 years
Phase:
NA
Brief Summary
Congenital heart disease (CHD) survivors constitute one of the fastest growing populations in adult cardiology practices. This population is vulnerable to gaps in care, particularly as they graduate f...
Detailed Description
Congenital heart disease (CHD) survivors constitute one of the fastest growing populations in adult cardiology practices. This population is vulnerable to gaps in care, particularly as they graduate f...
Eligibility Criteria
Inclusion
- moderate or complex CHD
- seen at outpatient cardiology clinic at participating pediatric hospital
Exclusion
- \< Grade 6 level of reading and comprehension
- heart transplantation
Key Trial Info
Start Date :
January 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2025
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT04463446
Start Date
January 10 2022
End Date
December 30 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2B7